Number of the records: 1
Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE'
Title Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101 'CREATE' / Šufliarsky J. ... [et al.] Another responsib. Šufliarsky, Jozef (Bibliographic antecedent) Redakcia Onkológia (Adapter) Note Annals of oncology, May 5 (2018) In Onkológia. -- ISSN 1336-8176. -- Roč. 13, č. 3 (2018), s. 222 Call number C 3069 MeSH Subject sarkóm svetlobunkový - farmakoterapia Keywords krizotinib Language English Country Slovakia Database ARTICLES 
article
Number of the records: 1